Technology News and Research

RSS

BioElectronics bags second place in the medical device category of the 2009 Wall Street Journal Innovation Award

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it has been selected as a runner up in the medical device category of the 2009 Wall Street Journal Innovation Awards unveiled in today's global editions and online. The award was given for the Company's wearable patch that uses pulsed electromagnetic energy to deliver drug-free pain relief for a variety of conditions.

14 Sep 2009

Spacelabs Healthcare launches its Sentinel Cardiology Information Management System in the U.S.

OSI Systems, Inc. (NASDAQ: OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has launched the Sentinel Cardiology Information Management System (“CIMS”) in the United States.

14 Sep 2009

Emergency Medical Associates to track swine flu movement with SAP business intelligence solutions

As families return from summer travels and children head back to school, Emergency Medical Associates (EMA) is preparing for a potential resurgence in the swine flu virus (H1N1) this fall. By using business intelligence (BI) solutions from SAP AG (NYSE: SAP), EMA will continue to pinpoint the movement of swine flu and alert federal organizations such as the Centers for Disease Control and Prevention (CDC) as well as 21 different emergency medical departments to patterns of outbreak.

14 Sep 2009

IntegraMed’s Attain IVF Program now offered at Dallas IVF

IntegraMed America, Inc. (NASDAQ: INMD), the nation’s leading provider of specialty healthcare services in emerging, technology-focused niches, today announced that Dallas IVF has begun offering IntegraMed’s Attain™ IVF Program, a course-of-treatment financing program that improves patient success rates with in vitro fertilization (IVF) fertility treatments.

14 Sep 2009

Celldex commences dosing patients in Phase 1/2 study of its CDX-1401 vaccine candidate

Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the first patient has been dosed in a Phase 1/2 study of its vaccine candidate, CDX-1401, in patients with malignant solid tumors that express NY-ESO-1. CDX-1401 is a fully human monoclonal antibody designed to selectively deliver the NY-ESO-1 antigen to dendritic cells to generate a robust immune response against cancer cells expressing NY-ESO-1.

14 Sep 2009

Calypso’s GPS for the Body technology installed at University Of Maryland Greenebaum Cancer Center

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated cancer center in Baltimore, now offers the Calypso® System to provide accurate, precise, real-time tumor tracking for cancer patients undergoing external beam radiation therapy.

14 Sep 2009

Systech International announces new software for SPT application

Systech International, innovator of Packaging Execution Systems (PES) for the pharmaceutical industry, today announced the availability of a new software release for its widely-deployed Serialized Product Tracking (SPT) application.

14 Sep 2009

Four additional patents increase SPO Medical's intellectual property portfolio to eight patents

SPO Medical Inc. (SPOM)s intellectual property (IP) portfolio to a total of eight patents. These latest patents, developed by the SPO Medical engineering team, increases the Company's technological competitive edge in providing innovative, high performance oximetry solutions for a variety of market applications.

14 Sep 2009

FDA clearance for PRO-STIM bone graft substitute

Wright Medical Group, Inc., a global orthopaedic medical device company, today announced the 510K clearance of PRO-STIM™ Injectable Osteoinductive Bone Graft Substitute. PRO-STIM™ graft is a composite grafting material that is injected through a small needle, hardens, and is replaced by the patient’s new bone over time.

14 Sep 2009

Corventis completes enrollment for clinical trials of its MUSIC program

Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced today enrollment completion of the company’s MUSIC (Multi-Sensor Monitoring in Congestive Heart Failure) program consisting of 2 trials: the MUSIC Asia (180 patients) and the pivotal MUSIC study (362 patients).

14 Sep 2009

Senator Bob Bennett speaks on healthcare at the UTC sponsored CEO Roundtable

Senator Bob Bennett recently discussed the state of the nation’s healthcare with a group of Utah CEOs at a CEO Roundtable sponsored by The Utah Technology Council (UTC), Utah’s premier technology and life science association.

14 Sep 2009

HFSA annual meeting features discussion on David Duncan's quest for personalized medicine

The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured a discussion by David Ewing Duncan titled "One Man's Quest for Personalized Medicine." Over the course of one year, Duncan submitted himself to hundreds of tests that could predict and even prevent future illness.

14 Sep 2009

IVIS Lumina XR in vivo imaging system from Caliper Life Sciences

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced the IVIS Lumina XR in vivo imaging system, the latest addition to the IVIS product family.

14 Sep 2009

AirStrip Technologies to provide HIT solution to Premier healthcare alliance

The Premier healthcare alliance has contracted with AirStrip Technologies™, L.P. to offer its 2,200 hospitals members a mobile healthcare information technology (HIT) solution to improve obstetrical (OB) care, patient safety and communication among healthcare providers.

14 Sep 2009

Protalix Biotherapeutics reports completion of its Phase III trial of prGCD

Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company’s proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.

14 Sep 2009

FDA approves St. Jude Medical's EnSite Velocity Cardiac Mapping System

St. Jude Medical, Inc. (NYSE: STJ) today announced U.S. Food and Drug Administration (FDA) clearance and U.S. launch of its EnSite Velocity™ Cardiac Mapping System. This new system has been designed to help physicians more efficiently diagnose and guide therapy to treat abnormal heart rhythms.

14 Sep 2009

Sunlight Research's report analyzes Amgen EPO US patent portfolio

Sunlight Research((TM)) - The Source for Patent Analysis today announced the release of its report analyzing Amgen, Inc.'s Erythropoietin (EPO) US patent portfolio.

14 Sep 2009

Preliminary results of Phase 2b clinical trial of AZ-104 announced by Alexza Pharmaceuticals

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced preliminary results from its 366 patient Phase 2b clinical trial of AZ-104 (Staccato(R) loxapine) in patients with migraine headache.

14 Sep 2009

Gen-Probe to merge industrial testing assets into an independent company

Gen-Probe Incorporated announced today that it is spinning off its industrial testing assets into a new, independent company focused on developing rapid, highly accurate molecular assays for biopharmaceutical production, water and food safety testing, and other applications.

14 Sep 2009

DSG’s eCaseLink EDC software used in Cipher's Phase 3 dermatology study

DSG Inc., an industry leader in clinical trial data collection and management, today announced that Cipher Pharmaceuticals (TSX:DND) is using electronic data capture (EDC) software and data management services from DSG. Cipher is using DSG’s eCaseLink™ for its Phase 3 dermatology study on its new compound for the treatment of severe acne.

14 Sep 2009

Technology News and Research

BioElectronics bags second place in the medical device category of the 2009 Wall Street Journal Innovation Award

Spacelabs Healthcare launches its Sentinel Cardiology Information Management System in the U.S.

Emergency Medical Associates to track swine flu movement with SAP business intelligence solutions

IntegraMed’s Attain IVF Program now offered at Dallas IVF

Celldex commences dosing patients in Phase 1/2 study of its CDX-1401 vaccine candidate

Calypso’s GPS for the Body technology installed at University Of Maryland Greenebaum Cancer Center

Systech International announces new software for SPT application

Four additional patents increase SPO Medical's intellectual property portfolio to eight patents

FDA clearance for PRO-STIM bone graft substitute

Corventis completes enrollment for clinical trials of its MUSIC program

Senator Bob Bennett speaks on healthcare at the UTC sponsored CEO Roundtable

HFSA annual meeting features discussion on David Duncan's quest for personalized medicine

IVIS Lumina XR in vivo imaging system from Caliper Life Sciences

AirStrip Technologies to provide HIT solution to Premier healthcare alliance

Protalix Biotherapeutics reports completion of its Phase III trial of prGCD

FDA approves St. Jude Medical's EnSite Velocity Cardiac Mapping System

Sunlight Research's report analyzes Amgen EPO US patent portfolio

Preliminary results of Phase 2b clinical trial of AZ-104 announced by Alexza Pharmaceuticals

Gen-Probe to merge industrial testing assets into an independent company

DSG’s eCaseLink EDC software used in Cipher's Phase 3 dermatology study

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News